Skip to main content

Breast Cancer

Edited by: Dr Marc Lippman

The Breast Cancer Collection is an invitation-only sister title of the Springer subscription journal, Breast Cancer Research and Treatment (BREA).

Invited submissions should choose the Breast Cancer Collection during submission, and include the invitation letter from Dr Lippman in their SpringerPlus cover letter.

For more information about how you can be considered for the Breast Cancer Collection, please speak to the editorial team at BREA.

 

Collection Articles:

Page 2 of 4

  1. As the breast cancer survivor population increases, the topic of screening these women for recurrences is increasingly relevant. In our institution, we use both breast MRI and mammography in the surveillance o...

    Authors: Chana Weinstock, Cristina Campassi, Olga Goloubeva, Kathleen Wooten, Susan Kesmodel, Emily Bellevance, Steven Feigenberg, Olga Ioffe and Katherine H R Tkaczuk
    Citation: SpringerPlus 2015 4:459
  2. Clinical trials and epidemiological evidence have shown that combined estrogen/progestin hormone replacement therapy, but not estrogen therapy alone, increases breast cancer risk in post-menopausal women. Pre...

    Authors: Matthew T. Cook, Yayun Liang, Cynthia Besch-Williford, Sandy Goyette, Benford Mafuvadze and Salman M. Hyder
    Citation: SpringerPlus 2015 4:444
  3. Desmopressin (dDAVP) is a well-known peptide analog of the antidiuretic hormone vasopressin, used to prevent excessive bleeding during surgical procedures. dDAVP increases hemostatic mediators, such as the von...

    Authors: Ruth S Weinberg, Marcelo O Grecco, Gimena S Ferro, Debora J Seigelshifer, Nancy V Perroni, Francisco J Terrier, Analía Sánchez-Luceros, Esteban Maronna, Ricardo Sánchez-Marull, Isabel Frahm, Marcelo D Guthmann, Daniela Di Leo, Eduardo Spitzer, Graciela N Ciccia, Juan Garona, Marina Pifano…
    Citation: SpringerPlus 2015 4:428
  4. Tamoxifen is an anti-estrogenic drug that is widely used for endocrine-dependent breast cancer as adjuvant hormonal therapy, and its use has been reported to be frequently associated with high levels of serum ...

    Authors: Rena Yamazaki, Masafumi Inokuchi, Satoko Ishikawa, Subaru Myojo, Junpei Iwadare, Yukiko Bono, Yasunari Mizumoto, Mitsuhiro Nakamura, Masahiro Takakura, Takashi Iizuka, Tetsuo Ohta and Hiroshi Fujiwara
    Citation: SpringerPlus 2015 4:425
  5. Physical activity (PA) has a myriad of benefits for breast cancer survivors, including a reduced risk of cancer recurrence. Latinas are less physically active than are women in the general population and littl...

    Authors: Daniel C Hughes, Maribel Tirado-Gomez, Liliana Vallejo, Velda Gonzalez, Rose A Treviño-Whitaker, Gabriela Villanueva and Karen Basen-Engquist
    Citation: SpringerPlus 2015 4:416
  6. To evaluate the reliability of the Attitudes to Randomized Trial Questionnaire (ARTQ) in measuring perceptions of cancer clinical trials in a predominantly African American (AA) sample in South Carolina (SC).

    Authors: Marvella E Ford, Wei Wei, Leslie A Moore, Dana R Burshell, Kimberly Cannady, Franshawn Mack, Nnadozie Ezerioha, Kelley Ercole and Elizabeth Garrett-Mayer
    Citation: SpringerPlus 2015 4:411
  7. Febrile neutropenia (FN) is a major dose-limiting toxicity of cancer chemotherapy resulting in considerable morbidity, mortality, and cost. This study evaluated the time course of neutropenic events and patter...

    Authors: Eva Culakova, Marek S Poniewierski, Debra A Wolff, David C Dale, Jeffrey Crawford and Gary H Lyman
    Citation: SpringerPlus 2015 4:396
  8. To determine whether exercise training improves autonomic function in women with breast cancer (BC).

    Authors: Francesco Giallauria, Luigi Maresca, Alessandra Vitelli, Maria Santucci de Magistris, Paolo Chiodini, Amalia Mattiello, Marco Gentile, Maria Mancini, Alessandra Grieco, Angelo Russo, Rosa Lucci, Giorgio Torella, Franco Berrino, Salvatore Panico and Carlo Vigorito
    Citation: SpringerPlus 2015 4:388
  9. We investigated in postmenopausal women with primary breast cancer prior to surgical intervention whether, serum levels of different steroid hormones and hormonal precursors associated with tumor tissue estrog...

    Authors: Borbála Vincze, Bence Kapuvári, Nóra Udvarhelyi, Zsolt Horváth, Zoltán Mátrai, Ferenc Czeyda-Pommersheim, Krisztina Kőhalmy, Judit Kovács, Mariann Boldizsár, István Láng and Miklós Kásler
    Citation: SpringerPlus 2015 4:387
  10. Breast cancer subtype, determined by expression of estrogen/progesterone receptor (ER/PR) and human epidermal growth factor receptor (HER)-2, is predictive for prognosis. The importance of subtype to locoregio...

    Authors: Chi Zhang, Shuang Wang, Hayley P Israel, Sherry X Yan, David P Horowitz, Seth Crockford, Daniela Gidea-Addeo, K S Clifford Chao, Kevin Kalinsky and Eileen P Connolly
    Citation: SpringerPlus 2015 4:386
  11. There is a significant difference in the mean tumor size between very young breast cancer patients and their elder counterparts. A simple comparison may show obvious prognostic differences. We investigated the...

    Authors: Masujiro Makita, Takehiko Sakai, Akemi Kataoka, Dai Kitagawa, Akiko Ogiya, Hidetomo Morizono, Yumi Miyagi, Kotaro Iijima, Kokoro Kobayashi, Takayuki Kobayashi, Ippei Fukada, Kazuhiro Araki, Shunji Takahashi, Yoshinori Ito, Naoya Gomi, Masahiko Oguchi…
    Citation: SpringerPlus 2015 4:365
  12. Mastectomy is effective treatment for ductal carcinoma in situ (DCIS) but some women will develop chest wall recurrence. Most chest wall recurrences that develop after mastectomy are invasive cancer and are as...

    Authors: Jonathan Klein, Iwa Kong, Lawrence Paszat, Sharon Nofech-Mozes, Wedad Hanna, Deva Thiruchelvam, Steven A. Narod, Refik Saskin, Susan J. Done, Naomi Miller, Bruce Youngson, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A. Jani, Elzbieta Slodkowska…
    Citation: SpringerPlus 2015 4:335
  13. Neoadjuvant chemotherapy (NCT) using anthracyclines and taxanes is a standard treatment for locally advanced breast cancer. Efficacy of NCT is however variable among patients and predictive markers are expecte...

    Authors: Aurélie Dumont, Diane Pannier, Agnès Ducoulombier, Emmanuelle Tresch, Jinying Chen, Andrew Kramar, Françoise Révillion, Jean-Philippe Peyrat and Jacques Bonneterre
    Citation: SpringerPlus 2015 4:327
  14. Pseudoangiomatous stromal hyperplasia (PASH) is a benign lesion often observed in parts of the mammary stroma in a variety of breast diseases. It is characterized by stromal myofibroblastic proliferation that ...

    Authors: Akiko Mizutou, Kazutaka Nakashima and Takuya Moriya
    Citation: SpringerPlus 2015 4:282
  15. Although its unclear oncological risk, which led to more than 20 years of prohibition of its use, fat grafting to the breast is widely used nowadays even for aesthetic purposes. Thus, we proposed an experiment...

    Authors: Francisco Claro Jr., Joseane Morari, Luciana R Moreira, Luís O Z Sarian, Glauce A Pinto, Licio A Velloso and Aarão M Pinto-Neto
    Citation: SpringerPlus 2015 4:279
  16. The aim of our study was to look for alternative predictive biomarkers for breast cancer management in limited resource setup. A comprehensive analysis of circulating cell-free DNA (CCFD) in serum at baseline ...

    Authors: Sobuhi Iqbal, Sreenivas Vishnubhatla, Vinod Raina, Surabhi Sharma, Ajay Gogia, Suryanarayana S V Deo, Sandeep Mathur and Nutan Kumar Shukla
    Citation: SpringerPlus 2015 4:265
  17. We have developed a new approach to reduce the serum interference for ELISA. The purpose of this study is to investigate if we can use the optimized ELISA (MBB-ELISA) to detect serum soluble HER2/neu (sHER2) i...

    Authors: Julia Tchou, Lian Lam, Yun Rose Li, Claire Edwards, Bonnie Ky and Hongtao Zhang
    Citation: SpringerPlus 2015 4:237
  18. Bilateral Breast Carcinoma (BBC) is a rare entity with incidence of synchronous carcinoma being 2-5% of all breast malignancies, which is much less than metachronous carcinoma. Synchronicity/ metachronicity ar...

    Authors: Vijay Kumar Shankarrao Kappikeri and Akshay Mahesh Kriplani
    Citation: SpringerPlus 2015 4:193
  19. Yoga-based exercise has proven to be beneficial for practitioners, including cancer survivors. This study reports on the effect on inflammatory biological markers for 20 breast cancer survivors who participate...

    Authors: Dorothy Long Parma, Daniel C Hughes, Sagar Ghosh, Rong Li, Rose A Treviño-Whitaker, Susan M Ogden and Amelie G Ramirez
    Citation: SpringerPlus 2015 4:143
  20. Primary small cell carcinomas of the breast (SCCB) are rare tumors with limited data on outcomes and treatment strategies. Using a population based approach, we aimed to study outcomes of SCCB and determine wh...

    Authors: Felicia Hare, Smith Giri, Jashmin K Patel, Andrew Hahn and Michael G Martin
    Citation: SpringerPlus 2015 4:138
  21. Breast cancer is the most common malignancy among women. Surgical treatment is an essential part of therapy, which still includes chemotherapy, radiotherapy and hormone therapy. The increase in early cancer de...

    Authors: Kassandra Ferreira Pessoa Fukushima, Luana Aroucha Carmo, Adriana Carvalho Borinelli and Caroline Wanderley Souto Ferreira
    Citation: SpringerPlus 2015 4:112
  22. Majority of the known breast cancer susceptibility genes have a role in DNA repair and the most important high-risk genes BRCA1 and BRCA2 are specifically involved in the homologous recombination repair (HRR) of ...

    Authors: Liisa M Pelttari, Johanna I Kiiski, Salla Ranta, Sara Vilske, Carl Blomqvist, Kristiina Aittomäki and Heli Nevanlinna
    Citation: SpringerPlus 2015 4:92
  23. The high expense of newer, more effective adjuvant endocrine therapy agents (aromatase inhibitors [AIs]) for postmenopausal breast cancer contributes to socioeconomic disparities in breast cancer outcomes. Thi...

    Authors: Ann Butler Nattinger, Liliana E Pezzin, Emily L McGinley, John A Charlson, Tina W F Yen and Joan M Neuner
    Citation: SpringerPlus 2015 4:54

    The Erratum to this article has been published in SpringerPlus 2015 4:531

  24. The cell-cycle checkpoint kinase 2 (CHEK2) is an important signal transducer of cellular responses to DNA damage, whose defects has been associated with increased risk for breast cancer. The CHEK2 1100delC mut...

    Authors: Chaymaa Marouf, Omar Hajji, Brehima Diakité, Amal Tazzite, Hassan Jouhadi, Abdellatif Benider and Sellama Nadifi
    Citation: SpringerPlus 2015 4:38
  25. Clinicians have traditionally used clinicopathological (CP) factors to determine locoregional recurrence (LR) risk of breast cancer and have generated the IBTR! nomogram to predict the risk of ipsilateral brea...

    Authors: Nikhil G Thaker, Karen E Hoffman, Michael C Stauder, Simona F Shaitelman, Eric A Strom, Welela Tereffe, Benjamin D Smith, George H Perkins, Lei Huo, Mark F Munsell, Lajos Pusztai, Thomas A Buchholz and Wendy A Woodward
    Citation: SpringerPlus 2015 4:36
  26. Doxorubicin (DOX) chemotherapy can cause cardiac complications. Angiotensin converting enzyme inhibitors (ACEI) may protect against these complications. We performed a pharmacokinetics (PK) study to determine ...

    Authors: Anne Blaes, Daniel Duprez, Todd Defor, Ryan Shanley, Heather Beckwith, Tufia Haddad, David Potter, Douglas Yee, Kinjal Sanghavi and Pamala Jacobson
    Citation: SpringerPlus 2015 4:32
  27. Invasive breast carcinoma is the most common cancer in women as in non-ovariectomised pet dogs, which are already identified as a valuable spontaneous preclinical model for that disease. Geographical and time ...

    Authors: Sabine Sévère, Philippe Marchand, Ingrid Guiffard, Floriane Morio, Anaïs Venisseau, Bruno Veyrand, Bruno Le Bizec, Jean-Philippe Antignac and Jérôme Abadie
    Citation: SpringerPlus 2015 4:27
  28. Considerable debate exists about the optimal treatment of ductal carcinoma in situ (DCIS). Using electronic data sources, we examined first course treatment patterns among women aged 18 years and older diagnosed ...

    Authors: Heather Spencer Feigelson, Nikki M Carroll, Sheila Weinmann, Reina Haque, Chu-Ling Yu, Melissa G Butler, Beth Waitzfelder, Michelle G Wrenn, Angela Capra, Elizabeth A McGlynn and Laurel A Habel
    Citation: SpringerPlus 2015 4:24
  29. To determine whether capecitabine (X), combined with docetaxel (T) following doxorubicin (A) and cyclophosphamide (C), enhanced the pathological complete response (pCR) in the breast and axillary lymph nodes (...

    Authors: Jennifer Eremin, Ged Cowley, Leslie G Walker, Elisabeth Murray, Monika Stovickova and Oleg Eremin
    Citation: SpringerPlus 2015 4:9
  30. This study was conducted in order to investigate the implications of the R72P polymorphism in the TP53 gene in breast cancer risk. The enlightenment of this matter might provide a piece of information about the p...

    Authors: Meire Luzia Gonçalves, Sarah Moreira Borja, Jacqueline Andréia Bernardes Leão Cordeiro, Vera Aparecida Saddi, Flávio Monteiro Ayres, Cesar Augusto Sam Tiago Vilanova-Costa and Antonio Márcio Teodoro Cordeiro Silva
    Citation: SpringerPlus 2014 3:749
  31. Familial breast and ovarian cancer prevalence was assessed among 1150 women of Mexican descent enrolled in a case-only, binational breast cancer study. Logistic regression was conducted to compare odds of trip...

    Authors: Kristin Anderson, Patricia A Thompson, Betsy C Wertheim, Lorena Martin, Ian K Komenaka, Melissa Bondy, Adrian Daneri-Navarro, Maria Mercedes Meza-Montenegro, Luis Enrique Gutierrez-Millan, Abenaa Brewster, Lisa Madlensky, Malaika Tobias, Loki Natarajan and María Elena Martínez
    Citation: SpringerPlus 2014 3:727
  32. In recent years, circulating miRNAs have attracted interest as stable, non-invasive biomarkers for various pathological conditions. Here, we investigated their potential to serve as minimally invasive, early d...

    Authors: Khouloud Hamdi, David Goerlitz, Neila Stambouli, Mohammed Islam, Olfa Baroudi, Bilel Neili, Farhat Benayed, Simon Chivi, Christopher Loffredo, Irene A Jillson, Amel Benammar Elgaaied, Jan K Blancato and Raja Marrakchi
    Citation: SpringerPlus 2014 3:636
  33. Here we investigate the feasibility of tumor metabolism monitoring in T1c to T3 breast cancer during neoadjuvant chemotherapy by means of phosphorus (31P) magnetic resonance spectroscopy at 7 tesla (T). Five brea...

    Authors: Wybe JM van der Kemp, Bertine L Stehouwer, Peter R Luijten, Maurice AAJ van den Bosch and Dennis WJ Klomp
    Citation: SpringerPlus 2014 3:634
  34. This paper investigates the distribution of age at diagnosis of female breast cancer and its association with temporal trend, clinicopathologic and sociodemographic variables in the presence of two latent clus...

    Authors: Gabriel Escarela, Luis Carlos Pérez-Ruiz and Gabriel Núñez-Antonio
    Citation: SpringerPlus 2014 3:626
  35. The humanized monoclonal antibody trastuzumab has been in routine use for chemotherapy for human epidermal growth factor receptor II (HER2)-positive breast cancer. A major adverse effect of trastuzumab is card...

    Authors: Kenichi Katsurada, Masaru Ichida, Masako Sakuragi, Megumi Takehara, Yasuo Hozumi and Kazuomi Kario
    Citation: SpringerPlus 2014 3:620
  36. While de-escalation of bisphosphonates from 4 to 12-weekly dosing has been shown to be clinically non-inferior to standard dosing, there is evidence the de-escalation is associated with increased bone turnover...

    Authors: Christina L Addison, Gregory R Pond, Huijun Zhao, Sasha Mazzarello, Lisa Vandermeer, Robyn Goldstein, Eitan Amir and Mark Clemons
    Citation: SpringerPlus 2014 3:577
  37. Triple negative breast cancer (TNBC) constitutes 10-15% of female breast cancers, and clinical guidelines recommend treatment with chemotherapy and surgery. We examined the recorded treatment and survival of w...

    Authors: Shrestha Pal, Margreet Lüchtenborg, Elizabeth A. Davies and Ruth H. Jack
    Citation: SpringerPlus 2014 3:553
  38. 18,000 women die due to metastatic breast cancer in Germany per year. Median survival is 20–28 months after diagnosis. The question we wanted to answer was whether survival has improved in routine care? For th...

    Authors: Rudolf Weide, Stefan Feiten, Vera Friesenhahn, Jochen Heymanns, Kristina Kleboth, Jörg Thomalla, Christoph van Roye and Hubert Köppler
    Citation: SpringerPlus 2014 3:535
  39. We hypothesized that improved acute postoperative pain relief will be achieved using general anaesthesia (GA) either in combination with continuous thoracic paravertebral block (GA-cPVB) or single shot (GA-sPV...

    Authors: Esther A C Bouman, Maurice Theunissen, Alfons GH Kessels, Kristien BMI Keymeulen, Elbert AJ Joosten, Marco AE Marcus, Wolfgang F Buhre and Hans-Fritz Gramke
    Citation: SpringerPlus 2014 3:517
  40. Scalp cooling is a long known method to reduce chemotherapy-induced alopecia in cancer patients with solid tumors. Due to a progress in this method, a medical device enabling individual feedback-controlled tem...

    Authors: Kay Friedrichs and Martin H Carstensen
    Citation: SpringerPlus 2014 3:500
  41. Subsequent to chemotherapy treatment, breast cancer patients often report a decline in cognitive functioning that can adversely impact many aspects of their lives. Evidence has mounted in recent years indicati...

    Authors: Chris Lepage, Andra M Smith, Jeremy Moreau, Emily Barlow-Krelina, Nancy Wallis, Barbara Collins, Joyce MacKenzie and Carole Scherling
    Citation: SpringerPlus 2014 3:444
  42. Triple-negative breast cancer (TNBC) is associated with a higher incidence of recurrence and distant metastasis and a poor prognosis, whereas effective treatment strategies remain to be established. Finding an...

    Authors: Masato Terashima, Kazuko Sakai, Yosuke Togashi, Hidetoshi Hayashi, Marco A De Velasco, Junji Tsurutani and Kazuto Nishio
    Citation: SpringerPlus 2014 3:417
  43. Racial disparities in breast reconstruction for breast cancer are documented. Place of service has contributed to disparities in cancer care; but the interaction of race/ethnicity and place of service has not ...

    Authors: Tracy Onega, Julie Weiss, Karla Kerlikowske, Karen Wernli, Diana SM Buist, Louise M Henderson, Martha Goodrich, Jennifer Alford-Teaster, Beth Virnig, Anna NA Tosteson, Wendy DeMartini and Rebecca Hubbard
    Citation: SpringerPlus 2014 3:416
  44. Identifying ductal carcinoma in situ (DCIS) patients at highest risk for recurrence after breast conserving surgery (BCS) remains a clinical concern. Subjecting all such patients to radiotherapy may be unneces...

    Authors: Taeryung Kim, Heung Kyu Park, Kyung Hee Lee, Kwan Il Kim, Kyu Chan Lee, Jeong Suk Ahn and Kwang-Pil Ko
    Citation: SpringerPlus 2014 3:405
  45. It is a well-established multidisciplinary practice at the European Institute of Oncology, that nurses and physicians often report their difficulties to clinical psychologists regarding adherence to hospital s...

    Authors: Paola Arnaboldi, Claudio Lucchiari, Luigi Santoro, Claudia Sangalli, Alberto Luini and Gabriella Pravettoni
    Citation: SpringerPlus 2014 3:392